Humana Analyst Ratings
Humana Analyst Ratings
Morgan Stanley Initiates Coverage On Humana With Equal-Weight Rating, Announces Price Target of $374
Barclays Adjusts Price Target on Humana to $370 From $326
Wolfe Research Adjusts Price Target on Humana to $400 From $373
Humana Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $360 Price Target
Stephens Adjusts Humana Price Target to $400 From $350
Wells Fargo Sticks to Their Buy Rating for Humana (HUM)
Humana Analyst Ratings
Humana (HUM.US) was first covered by Baird, which gave it a neutral rating, with a target price of $374.00.
Wolfe Research Raises Humana's Price Target to $400 From $373
Bank of America raised Humana's target price to $376
Humana Analyst Ratings
B of A Securities Maintains Neutral on Humana, Raises Price Target to $376
B of A Securities: Maintaining the Humana (HUM.US) rating, adjusted from neutral to neutral, and adjusted the target price from $342.00 to $376.00.
Humana: Hold Rating Amid Short-Term Pressures and Long-Term Optimism
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), NewAmsterdam Pharma Company (NAMS) and Humana (HUM)
Deutsche Bank Adjusts Price Target on Humana to $341 From $355
Buy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain Strong